Biotage AB Valuation
| BITGF Stock | USD 16.87 0.00 0.00% |
At this time, the firm appears to be overvalued. Biotage AB shows a prevailing Real Value of $15.65 per share. The current price of the firm is $16.87. Our model approximates the value of Biotage AB from analyzing the firm fundamentals such as Shares Outstanding of 65.98 M, return on equity of 0.18, and Profit Margin of 0.16 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Biotage AB's price fluctuation is somewhat reliable at this time. Calculation of the real value of Biotage AB is based on 3 months time horizon. Increasing Biotage AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Biotage AB is useful when determining the fair value of the Biotage otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Biotage AB. Since Biotage AB is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biotage OTC Stock. However, Biotage AB's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.87 | Real 15.65 | Hype 16.87 |
The real value of Biotage OTC Stock, also known as its intrinsic value, is the underlying worth of Biotage AB OTC Stock, which is reflected in its stock price. It is based on Biotage AB's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Biotage AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biotage AB's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biotage AB helps investors to forecast how Biotage otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biotage AB more accurately as focusing exclusively on Biotage AB's fundamentals will not take into account other important factors: Biotage AB Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Biotage AB's current stock value. Our valuation model uses many indicators to compare Biotage AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biotage AB competition to find correlations between indicators driving Biotage AB's intrinsic value. More Info.Biotage AB is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies fabricating about 0.13 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Biotage AB is roughly 7.48 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biotage AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biotage AB's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotage AB's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Biotage AB's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Biotage AB and how it compares across the competition.
About Biotage AB Valuation
The otc valuation mechanism determines the current worth of Biotage AB on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Biotage AB. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of Biotage AB based exclusively on its fundamental and basic technical indicators. By analyzing Biotage AB's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Biotage AB's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biotage AB. We calculate exposure to Biotage AB's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Biotage AB's related companies.Biotage AB provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. Biotage AB was founded in 1969 and is headquartered in Uppsala, Sweden. Biotage Ab is traded on OTC Exchange in the United States.
8 Steps to conduct Biotage AB's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Biotage AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Biotage AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Biotage AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Biotage AB's revenue streams: Identify Biotage AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Biotage AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Biotage AB's growth potential: Evaluate Biotage AB's management, business model, and growth potential.
- Determine Biotage AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Biotage AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of Biotage AB represents a small ownership stake in the entity. As a stockholder of Biotage, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Biotage AB Dividends Analysis For Valuation
Please note that Biotage AB has scaled down on payment of dividends at this time.
There are various types of dividends Biotage AB can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Biotage shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Biotage AB directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Biotage pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Biotage AB by the value of the dividends paid out.
Biotage AB Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Biotage AB does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 66 M | |
| Quarterly Earnings Growth Y O Y | 0.21 | |
| Retained Earnings | 1.1 B |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotage AB. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Biotage AB information on this page should be used as a complementary analysis to other Biotage AB's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Biotage OTC Stock analysis
When running Biotage AB's price analysis, check to measure Biotage AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotage AB is operating at the current time. Most of Biotage AB's value examination focuses on studying past and present price action to predict the probability of Biotage AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotage AB's price. Additionally, you may evaluate how the addition of Biotage AB to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |